UK markets closed

Santhera Pharmaceuticals Holding AG (0QN1.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.8037-0.4963 (-38.18%)
At close: 05:04PM BST
Full screen
Previous close1.3000
Open0.8037
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.8037 - 0.8037
52-week range0.8037 - 0.8037
Volume6,431
Avg. volumeN/A
Market cap91,465
Beta (5Y monthly)1.19
PE ratio (TTM)N/A
EPS (TTM)-1.6250
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting

    Pratteln, Switzerland, June 30, 2022 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Annual General Meeting (AGM) held today at the Company’s domicile in Pratteln, Switzerland. In total, 14,118,025 shares equaling 19.2% of the Company’s share capital were represented. Approval of the 2021 Annual Report, results appropriation, allocation of reserves and dischargeThe shareholders endorsed the Annual Report, the ann

  • Globe Newswire

    Santhera Updates on Ongoing NDA Submission for Vamorolone

    Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 29, 2022 – Santhera Pharmaceuticals (SIX: SANN) announces that the clinical module of its rolling new drug application (NDA) for vamorolone in Duchenne muscular dystrophy (DMD) has been submitted to the U.S. Food and Drug Administration (FDA). Finalization of the NDA submission to start the FDA official review is postponed by 4-6 months to Q4-2022 after a third-party contract manufacturing organization (CMO) communicated a de

  • Globe Newswire

    Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board

    Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 27, 2022 -- Santhera Pharmaceuticals (SIX: SANN) announces that Chairman of the Board Elmar Schnee will not stand for re-election at the upcoming Annual General Meeting on June 30, 2022. The Board of Directors has unanimously nominated Thomas Meier, PhD, for election as Chairman of the Board and as member of the Compensation Committee. Elmar Schnee, Chairman of the Board and member of the Compensation Committee of Santhera si